Measures in the health sector included a reduction in health workers' salaries, cuts to public pharmaceutical expenditure and a price review of private providers. Medical practices were also targeted with the introduction of clinical guidelines. Recent efforts have targeted changes to provider payment mechanisms, the development of Health Technology Assessment and defining a national list of pharmaceutical products and prescription guidelines.